MedPath

Feasibility study of sentinel lymph node biopsy following neoadjuvant chemotherapy in breast cancer patients

Not Applicable
Conditions
breast cancer
Registration Number
JPRN-UMIN000006534
Lead Sponsor
Sentinel Lymph node biopsy following neoadjuvant chemotherapy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
240
Inclusion Criteria

Not provided

Exclusion Criteria

1.History of undergo sentinel lymph node biopsy 2.Ipsilateral breast tumor recurrence 3.Inflammatory breast cancer 4.Bilateral breast cancer 5.Women during pregnancy or breast-feeding. 6.Disqualified by doctors

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath